These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29702524)

  • 1. Genetic convergence of rare lymphomas.
    Shingleton JR; Dave SS
    Curr Opin Hematol; 2018 Jul; 25(4):307-314. PubMed ID: 29702524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas.
    Turakhia S; Lanigan C; Hamadeh F; Swerdlow SH; Tubbs RR; Cook JR
    Am J Clin Pathol; 2015 Jul; 144(1):87-93. PubMed ID: 26071465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
    Romano E; Pradervand S; Paillusson A; Weber J; Harshman K; Muehlethaler K; Speiser D; Peters S; Rimoldi D; Michielin O
    Clin Cancer Res; 2013 Oct; 19(20):5749-57. PubMed ID: 23948972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF--a new player in hematological neoplasms.
    Machnicki MM; Stoklosa T
    Blood Cells Mol Dis; 2014; 53(1-2):77-83. PubMed ID: 24495477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E Mutation in Involuting Nevus in a Patient Treated With Vemurafenib.
    Millán-Cayetano JF; Fernández-Canedo I; Blázquez-Sánchez N; Fúnez-Liébana R; de Troya-Martín M
    JAMA Dermatol; 2017 Jun; 153(6):605-607. PubMed ID: 28249088
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
    Rossi D; Ciardullo C; Gaidano G
    Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormalities of signal transduction molecules in multiple myeloma].
    Sasaki M; Komatsu N
    Nihon Rinsho; 2015 Jan; 73(1):62-8. PubMed ID: 25626306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of BRAF V600E protein expression in primary central nervous system lymphoma.
    Berghoff AS; Capper D; Preusser M
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):351-3. PubMed ID: 23235345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
    Bailey NG; Elenitoba-Johnson KSJ
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia.
    Arora N; Nair S; Pai R; Nair S; Ahmed R; Abraham A; Viswabandya A; George B; Balasubramanian P; Srivastava A; Mathews V
    Indian J Pathol Microbiol; 2015; 58(1):62-5. PubMed ID: 25673595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing.
    Vacca D; Cancila V; Gulino A; Lo Bosco G; Belmonte B; Di Napoli A; Florena AM; Tripodo C; Arancio W
    Mol Biol Rep; 2018 Feb; 45(1):1-7. PubMed ID: 29238890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib.
    Kim GH; Levy A; Compoginis G
    J Cutan Pathol; 2013 Jul; 40(7):667-9. PubMed ID: 23581649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrosequencing of BRAF V600E in routine samples of hairy cell leukaemia identifies CD5+ variant hairy cell leukaemia that lacks V600E.
    Lennerz JK; Klaus BM; Marienfeld RB; Möller P
    Br J Haematol; 2012 Apr; 157(2):267-9. PubMed ID: 22145942
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
    Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
    Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
    van den Hurk K; Balint B; Toomey S; O'Leary PC; Unwin L; Sheahan K; McDermott EW; Murphy I; van den Oord JJ; Rafferty M; FitzGerald DM; Moran J; Cummins R; MacEneaney O; Kay EW; O'Brien CP; Finn SP; Heffron CC; Murphy M; Yela R; Power DG; Regan PJ; McDermott CM; O'Keeffe A; Orosz Z; Donnellan PP; Crown JP; Hennessy BT; Gallagher WM
    Melanoma Res; 2015 Jun; 25(3):189-99. PubMed ID: 25746038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vemurafenib.
    Garbe C; Abusaif S; Eigentler TK
    Recent Results Cancer Res; 2014; 201():215-25. PubMed ID: 24756795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of genomic alterations in primary central nervous system lymphomas.
    Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
    J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
    Duquette M; Sadow PM; Husain A; Sims JN; Antonello ZA; Fischer AH; Song C; Castellanos-Rizaldos E; Makrigiorgos GM; Kurebayashi J; Nose V; Van Hummelen P; Bronson RT; Vinco M; Giordano TJ; Dias-Santagata D; Pandolfi PP; Nucera C
    Oncotarget; 2015 Dec; 6(40):42445-67. PubMed ID: 26636651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.
    Robinson SD; O'Shaughnessy JA; Cowey CL; Konduri K
    Lung Cancer; 2014 Aug; 85(2):326-30. PubMed ID: 24888229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.